Hatch Takes Aim At Kennedy’s Commissioner Criteria, Supports Crawford
This article was originally published in The Gray Sheet
Executive Summary
Ties to an FDA-regulated industry should not preclude a candidate's nomination to the agency's top position, Sen. Orrin Hatch (R-Utah) asserted April 16 at the Food & Drug Law Institute Educational Conference in Washington, D.C